Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | TDOC |
---|---|---|
10:44 ET | 300 | 18.26 |
10:49 ET | 100 | 18.3 |
01:18 ET | 100 | 18.42 |
01:49 ET | 3600 | 18.39 |
02:09 ET | 100 | 18.4 |
02:16 ET | 100 | 18.4 |
02:32 ET | 200 | 18.44 |
US Equity | 67.9% |
---|---|
Int'l Equity | 31.9% |
Other | 0.1% |
Cash | 0.1% |
CDN Equity | 0 |
Fixed Income | 0 |
Healthcare | 99.7% |
---|---|
Technology | 0.2% |
Basic Mat. | 0 |
Communication Services | 0 |
Consumer Cyclical | 0 |
Consumer Defensive | 0 |
Energy | 0 |
Financial Serv.s | 0 |
Industrials | 0 |
Real Estate | 0 |
Utilities | 0 |
United States | 68.0% |
---|---|
Asia/Oceania | 11.8% |
Europe | 6.0% |
Africa | 0 |
Latin America | 0 |
Canada | 0 |
Company Name sortable | Position sortable | Allocation sortable | Allocation sortable1 Month Change | Market Value sortable |
---|---|---|---|---|
Bristol-Myers Squibb Co | Long | 2.7% | +0.21% | $2.5M |
Gilead Sciences Inc | Long | 2.6% | +0.22% | $2.4M |
AbbVie Inc | Long | 2.4% | +0.23% | $2.3M |
Medtronic PLC | Long | 2.3% | +0.24% | $2.2M |
Intuitive Surgical Inc | Long | 2.3% | +0.27% | $2.1M |
UnitedHealth Group Inc | Long | 2.2% | +0.19% | $2.1M |
Roche Holding AG | Long | 2.2% | +0.23% | $2.1M |
Abbott Laboratories | Long | 2.2% | +0.25% | $2.1M |
Boston Scientific Corp | Long | 2.2% | 0.00% | $2.0M |
Johnson & Johnson | Long | 2.1% | +0.26% | $2.0M |
Time Horizon | Star Rating |
---|---|
Overall Rating | Not Rated |
3 Year Rating | Not Rated |
5 Year Rating | Not Rated |
10 Year Rating | Not Rated |
Past performance is no guarantee of future results. The ratings reflect historical risk-adjusted performance, and the overall rating is derived from a weight average of the fund's 3, 5, and 10 year (Morningstar Rating) metrics.
Style Box is calculated only using the long position holdings of the portfolio.
Best Fit Index | --- |
---|---|
Category | Sector Equity |
Sponsor | TD Asset Management Inc |
Inception | April 7, 2021 |
TD Global Healthcare Leaders Index ETF seeks to track, to the extent reasonably possible and before the deduction of fees and expenses, the performance of a global equity index which measures the investment return of global issuers related to healthcare. Currently, this TD ETF seeks to track the Solactive Global Healthcare Leaders Index (CA NTR) (or any successor thereto).
Total Net Assets | $90.6M |
---|---|
Shares Out. | 4.8M |
Net Asset Value (NAV) | $18.34 |
Prem/Discount to NAV | -0.11% |
P/E Ratio | 30.9 |
Dividend Yield | 2.46% |
Dividend per Share | --- |
Ex-Dividend Date | --- |
Dividend Payment Date | --- |
Beta | --- |
Morningstar Investment Style | Sector Equity |
Equity Style | Large Cap Blend |
Credit Quality / Duration | --- |
Actual Management Fee | 0.35% |
---|---|
Actual Mgmt. Expense Ratio (MER) | 0.39% |